The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTFB.L Regulatory News (MTFB)

  • There is currently no data for MTFB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

24 Nov 2016 13:36

RNS Number : 1003Q
Motif Bio PLC
24 November 2016
 

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

Motif Bio Plc

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

No

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

No

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

No

An event changing the breakdown of voting rights

No

Other (please specify):

Placing of Shares

Yes

3. Full name of person(s) subject to thenotification obligation: iii

Invesco Limited

4. Full name of shareholder(s)  (if different from 3.):iv

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

23 November 2016

6. Date on which issuer notified:

24 November 2016

7. Threshold(s) that is/are crossed orreached: vi, vii

26%, 27%

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

Ordinary 0.1p Shares

 

27,600,000

27,600,000

49,416,000

27.36%

GB00BVVT4H71

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

Nominal

Delta

Total (A+B+C)

Number of voting rights

Percentage of voting rights

49,416,000

27.36%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

Invesco Asset Management Limited - 49,416,000

Proxy Voting:

10. Name of the proxy holder:

Invesco Limited

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

14. Contact name:

Philippa Holmes

15. Contact telephone number:

01491 417 447

 

Note: Annex should only be submitted to the FCA not the issuer

Annex: Notification of major interests in share

A: Identity of the persons or legal entity subject to the notification obligation

Full name

(including legal form of legal entities)

 

Contact address

(registered office for legal entities)

 

Phone number & email

 

Other useful information

(at least legal representative for legal persons)

 

B: Identity of the notifier, if applicable

Full name

 

Invesco (UK) Limited

Contact address

 

Perpetual Park, Perpetual Park Drive, Henley-on-Thames. Oxon. RG9 1HH

Phone number & email

 

01491 417000

Other useful information

(e.g. functional relationship with the person or legal entity subject to the notification obligation)

C: Additional information

For notes on how to complete form TR-1 please see the FCA website.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLLLFVVLFLSFIR
Date   Source Headline
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:39 pmRNSPrice Monitoring Extension
18th Mar 20207:00 amRNSCorporate Update
12th Mar 20204:42 pmRNSSecond Price Monitoring Extn
12th Mar 20204:36 pmRNSPrice Monitoring Extension
12th Mar 202012:02 pmRNSPrice Monitoring Extension
7th Feb 20204:35 pmRNSPrice Monitoring Extension
28th Jan 20204:40 pmRNSSecond Price Monitoring Extn
28th Jan 20204:35 pmRNSPrice Monitoring Extension
28th Jan 20207:00 amRNSCorporate Update
22nd Jan 20204:40 pmRNSSecond Price Monitoring Extn
22nd Jan 20204:35 pmRNSPrice Monitoring Extension
17th Jan 202012:12 pmRNSHolding(s) in Company
16th Jan 20204:41 pmRNSSecond Price Monitoring Extn
16th Jan 20204:35 pmRNSPrice Monitoring Extension
16th Jan 202012:07 pmRNSSecond Price Monitoring Extn
16th Jan 202012:02 pmRNSPrice Monitoring Extension
14th Jan 202012:35 pmRNSHolding(s) in Company
10th Jan 20209:55 amRNSHolding(s) in Company
6th Jan 20204:40 pmRNSSecond Price Monitoring Extn
6th Jan 20204:35 pmRNSPrice Monitoring Extension
3rd Jan 202010:42 amRNSHolding(s) in Company
23rd Dec 20199:45 amRNSHolding(s) in Company
19th Dec 20194:29 pmRNSHolding(s) in Company
19th Dec 20194:25 pmRNSHolding(s) in Company
10th Dec 20197:00 amRNSVoluntary delisting from the NASDAQ Capital Market
6th Dec 201911:14 amRNSHolding(s) in Company
29th Nov 201912:20 pmRNSHolding(s) in Company
29th Nov 20197:00 amRNSTotal Voting Rights
27th Nov 20197:00 amRNSADS Program and Warrant Agent Agreement
26th Nov 20197:00 amRNSVoluntary Delisting from the Nasdaq Capital Market
20th Nov 20195:51 pmRNSHolding(s) in Company
18th Nov 201912:12 pmRNSDirectorate Changes
14th Nov 20196:13 pmRNSResult of General Meeting
11th Nov 20197:00 amRNSSettlement Agreement
28th Oct 20194:14 pmRNSHolding(s) in Company
25th Oct 20193:51 pmRNSHolding(s) in Company
25th Oct 201912:07 pmRNSSecond Price Monitoring Extn
25th Oct 201912:02 pmRNSPrice Monitoring Extension
25th Oct 20197:00 amRNSPosting of Circular and Notice of General Meeting
24th Oct 20197:00 amRNSU.S. Army-funded project to Evaluate Iclaprim
21st Oct 20193:00 pmRNSTiming of General Meeting and Circular
21st Oct 201912:07 pmRNSSecond Price Monitoring Extn
21st Oct 201912:02 pmRNSPrice Monitoring Extension
10th Oct 20197:00 amRNSMotif Bio confirms receipt of FDA meeting minutes
3rd Oct 201912:07 pmRNSSecond Price Monitoring Extn
3rd Oct 201912:02 pmRNSPrice Monitoring Extension
3rd Oct 20197:00 amRNSChange of Adviser
2nd Oct 20197:00 amRNSConditional Placing
30th Sep 20194:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.